Back to Search
ROBERT FRYER, M.D.
M.D.
Neurology with Special Qualifications in Child Neurology Physician
NPI: 1821006636Individual
Specialties, Licenses & Credentials
Neurology with Special Qualifications in Child Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology with Special Qualifications in Child Neurology
Code: 2084N0402X
223225(NY)
Research & Publications (20)
Sickle cell anemia with moyamoya disease: outcomes after EDAS procedure.
PMID 14580655·Pediatr Neurol·2003
8-other
Effect of the multitargeted receptor tyrosine kinase inhibitor, ABT-869 [N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea], on blood pressure in conscious rats and mice: reversal with antihypertensive agents and effect on tumor growth inhibition.
PMID 19255283·J Pharmacol Exp Ther·2009
7-preclinical
Recent advances and developments in treatment strategies against pancreatic cancer.
PMID 19442075·Curr Clin Pharmacol·2009
6-review
Experimental study of the susceptibility of Atlantic cod, Gadus morhua (L.), to infection with an IPNV strain pathogenic for Atlantic salmon, Salmo salar L.
PMID 19392683·J Fish Dis·2009
7-preclinical
Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermia.
PMID 19135797·Pain·2009
7-preclinical
Antagonism of TRPV1 receptors indirectly modulates activity of thermoregulatory neurons in the medial preoptic area of rats.
PMID 19236852·Brain Res·2009
7-preclinical
ETA receptor blockade with atrasentan prevents hypertension with the multitargeted tyrosine kinase inhibitor ABT-869 in telemetry-instrumented rats.
PMID 19188829·J Cardiovasc Pharmacol·2009
7-preclinical
Reduced heart size and increased myocardial fuel substrate oxidation in ACC2 mutant mice.
PMID 18487439·Am J Physiol Heart Circ Physiol·2008
7-preclinical
Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs.
PMID 17982006·Am J Physiol Heart Circ Physiol·2008
4-observational
Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema.
PMID 18084312·Br J Pharmacol·2008
7-preclinical
Evoked changes in cardiovascular function in rats by infusion of levosimendan, OR-1896 [(R)-N-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)acetamide], OR-1855 [(R)-6-(4-aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one], dobutamine, and milrinone: comparative effects on peripheral resistance, cardiac output, dP/dt, pulse rate, and blood pressure.
PMID 18171907·J Pharmacol Exp Ther·2008
4-observational
Composition and concentration of hydrocarbons in sediment samples from the oil producing area of the East Shetland Basin, Scotland.
PMID 18385878·J Environ Monit·2008
8-other
Preclinical characterization of A-582941: a novel alpha7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing properties.
PMID 18482100·CNS Neurosci Ther·2008
6-review
Systemic activation of the calcium sensing receptor produces acute effects on vascular tone and circulatory function in uremic and normal rats: focus on central versus peripheral control of vascular tone and blood pressure by cinacalcet.
PMID 17636005·J Pharmacol Exp Ther·2007
7-preclinical
Differential inhibition of renin mRNA expression by paricalcitol and calcitriol in C57/BL6 mice.
PMID 17622742·Nephron Physiol·2007
7-preclinical
Synthesis, potency, and in vivo profiles of quinoline containing histamine H3 receptor inverse agonists.
PMID 17918921·J Med Chem·2007
7-preclinical
Bcl-2 family proteins are essential for platelet survival.
PMID 17205078·Cell Death Differ·2007
7-preclinical
Discovery of 2-[4-{{2-(2S,5R)-2-cyano-5-ethynyl-1-pyrrolidinyl]-2-oxoethyl]amino]- 4-methyl-1-piperidinyl]-4-pyridinecarboxylic acid (ABT-279): a very potent, selective, effective, and well-tolerated inhibitor of dipeptidyl peptidase-IV, useful for the treatment of diabetes.
PMID 17034148·J Med Chem·2006
7-preclinical
Discovery of ((4R,5S)-5-amino-4-(2,4,5- trifluorophenyl)cyclohex-1-enyl)-(3- (trifluoromethyl)-5,6-dihydro- [1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanone (ABT-341), a highly potent, selective, orally efficacious, and safe dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
PMID 17064063·J Med Chem·2006
7-preclinical
Optimization of chromone-2-carboxamide melanin concentrating hormone receptor 1 antagonists: assessment of potency, efficacy, and cardiovascular safety.
PMID 17064075·J Med Chem·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 180 FORT WASHINGTON AVE
NEW YORK, NY 10032 - Phone
- (646) 426-3876
Quick Facts
- NPI
- 1821006636
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile